A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Authors
Keywords
Immunopharmacology, Pharmacogenetics, Pregnancy, Rheumatoid arthritis, Rituximab
Journal
CLINICAL RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-01
DOI
10.1007/s10067-019-04699-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden
- (2019) Kathrine Lederballe Grøn et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
- (2019) Jacques-Eric Gottenberg et al. BMJ-British Medical Journal
- Real-world effectiveness and safety of rituximab in the treatment of rheumatoid arthritis: A single-center experience in Taiwan
- (2019) Kai-Chun Wang et al. International Journal of Rheumatic Diseases
- Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial
- (2019) Chang-Hee Suh et al. BIODRUGS
- Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review
- (2019) Sonali Wijetilleka et al. AUTOIMMUNITY REVIEWS
- Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis
- (2019) Annalisa Fui et al. INTERNAL MEDICINE JOURNAL
- Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation
- (2019) Yi‐Ming Chen et al. International Journal of Rheumatic Diseases
- Infection risks of rituximab versus non‐rituximab treatment for rheumatoid arthritis: A systematic review and meta‐analysis
- (2019) Yuhong Shi et al. International Journal of Rheumatic Diseases
- Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial
- (2019) Seung Cheol Shim et al. RHEUMATOLOGY
- Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases
- (2018) S. Tavakolpour et al. CLINICAL GENETICS
- A multi-parameter response prediction model for rituximab in rheumatoid arthritis
- (2018) Tamarah D. de Jong et al. JOINT BONE SPINE
- Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
- (2018) Won Park et al. mAbs
- Long-term persistence with rituximab in patients with rheumatoid arthritis
- (2018) Alexander G S Oldroyd et al. RHEUMATOLOGY
- An Extension Study of PF-05280586, a Potential Rituximab Biosimilar, versus Rituximab in Subjects with Active Rheumatoid Arthritis
- (2018) Stanley B Cohen et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis
- (2018) Josef S. Smolen et al. Nature Reviews Disease Primers
- Efficacy and Safety of Hepatitis B Vaccination in Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drugs and/or Biologics Therapy
- (2018) Samanan Intongkam et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study
- (2018) Gillian Wheater et al. PLoS One
- Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration
- (2018) K Chatzidionysiou et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Infusion-related reactions to rituximab: frequency, mechanisms and predictors
- (2018) Franciane Paul et al. Expert Review of Clinical Immunology
- Comparative efficacy and safety of biosimilar rituximab and originator rituximab in combination with methotrexate in patients with active rheumatoid arthritis: A Bayesian network meta-analysis
- (2018) Sang-Cheol Bae et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis
- (2018) Alberto Jiménez Morales et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis
- (2018) Tamara H Ramwadhdoebe et al. RHEUMATOLOGY
- Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE Registry
- (2018) Kevin L Winthrop et al. ARTHRITIS CARE & RESEARCH
- Safety and Immunogenicity of Rituximab Biosimilar GP2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis
- (2018) Hans-Peter Tony et al. ARTHRITIS CARE & RESEARCH
- Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges
- (2017) Soheil Tavakolpour IMMUNOLOGY LETTERS
- Safe Use of Rituximab in an Elderly Patient With Rheumatoid Arthritis and Severe Heart Failure
- (2017) Sehun Lee et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments
- (2017) Gaëlle Clavel et al. JOINT BONE SPINE
- Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration
- (2017) Katerina Chatzidionysiou et al. JOURNAL OF RHEUMATOLOGY
- Prediction of Response to Targeted Treatment in Rheumatoid Arthritis
- (2017) C.A. Wijbrandts et al. MAYO CLINIC PROCEEDINGS
- Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection
- (2017) Julien Henry et al. RHEUMATOLOGY
- Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data
- (2017) Jean-Hugues Salmon et al. RHEUMATOLOGY
- An unexpected response to rituximab in a patient with rheumatoid arthritis
- (2017) Frédéric Coutant et al. RHEUMATOLOGY
- Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab
- (2017) Diederik De Cock et al. RHEUMATOLOGY
- Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre
- (2017) Md Yuzaiful Md Yusof et al. RHEUMATOLOGY
- OUP accepted manuscript
- (2017) RHEUMATOLOGY
- The role of autoantibodies in the pathophysiology of rheumatoid arthritis
- (2017) V. F. A. M. Derksen et al. Seminars in Immunopathology
- Correlação entre expressão celular de proteínas reguladoras do complemento com a depleção e repopulação de linfócitos B no sangue periférico de pacientes com artrite reumatoide tratada com rituximabe
- (2017) Daniela Viecceli et al. Revista Brasileira De Reumatologia
- The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis
- (2017) Šekib Sokolović et al. Bosnian Journal of Basic Medical Sciences
- Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis
- (2016) Jaqueline Barbeito de Vasconcellos et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Persistence of babesiosis for >2 years in a patient on rituximab for rheumatoid arthritis
- (2016) John Raffalli et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
- (2016) V. Varisco et al. JOURNAL OF RHEUMATOLOGY
- Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
- (2016) Duncan Porter et al. LANCET
- The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis
- (2016) Lucía Silva-Fernández et al. RHEUMATOLOGY
- BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1
- (2016) Julia Flint et al. RHEUMATOLOGY
- Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry
- (2016) Leslie R. Harrold et al. ARTHRITIS CARE & RESEARCH
- Epstein-Barr virus in peripheral blood is associated with response to rituximab therapy in rheumatoid arthritis patients
- (2015) Heikki Valleala et al. CLINICAL RHEUMATOLOGY
- Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis
- (2015) Markus Bredemeier et al. CLINICAL RHEUMATOLOGY
- Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti–Tumor Necrosis Factor Drugs
- (2015) Heikki Valleala et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry
- (2015) L. R. Harrold et al. JOURNAL OF RHEUMATOLOGY
- Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy
- (2015) K. J. Aaltonen et al. JOURNAL OF RHEUMATOLOGY
- Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years
- (2015) R. F. van Vollenhoven et al. JOURNAL OF RHEUMATOLOGY
- The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis: Fig. 1
- (2015) Clémentine Gamonet et al. RHEUMATOLOGY
- Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab
- (2015) Silvia Piantoni et al. RHEUMATOLOGY INTERNATIONAL
- Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis
- (2014) P B Lehane et al. ANNALS OF THE RHEUMATIC DISEASES
- A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
- (2014) Yi-Ming Chen et al. ANNALS OF THE RHEUMATIC DISEASES
- An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial
- (2014) Edward M Vital et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study
- (2014) Charles H Pritchard et al. BMC MUSCULOSKELETAL DISORDERS
- High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis
- (2014) Anaïs Gardette et al. JOINT BONE SPINE
- Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab
- (2014) R. Abdulkader et al. JOURNAL OF RHEUMATOLOGY
- Longterm Followup of Rituximab Therapy in Patients with Rheumatoid Arthritis: Results from the Belgian MabThera in Rheumatoid Arthritis Registry
- (2014) F. De Keyser et al. JOURNAL OF RHEUMATOLOGY
- Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
- (2014) Isabelle Duroux-Richard et al. MEDIATORS OF INFLAMMATION
- Statins Do Not Influence Long-Term Rituximab Clinical Efficiency in Rheumatoid Arthritis Patients
- (2014) Diana Mazilu et al. Biomed Research International
- Use of Whole-Blood Transcriptomic Profiling to Highlight Several Pathophysiologic Pathways Associated With Response to Rituximab in Patients With Rheumatoid Arthritis: Data From a Randomized, Controlled, Open-Label Trial
- (2014) Jérémie Sellam et al. Arthritis & Rheumatology
- Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study
- (2013) Luca Quartuccio et al. ANNALS OF THE RHEUMATIC DISEASES
- Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
- (2013) Joachim Listing et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response
- (2013) J. Mélet et al. ARTHRITIS AND RHEUMATISM
- Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al.
- (2013) Roberta Gualtierotti et al. CLINICAL RHEUMATOLOGY
- Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases
- (2013) Mario Ojeda-Uribe et al. CLINICAL RHEUMATOLOGY
- A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice
- (2013) Dave Nicholls et al. International Journal of Rheumatic Diseases
- Severe Pasteurella multocida infection in a patient on rituximab therapy for rheumatoid arthritis
- (2013) Alban Rouil et al. JOINT BONE SPINE
- Widespread psoriasis induced by rituximab in a patient with rheumatoid arthritis: An unexpected adverse reaction
- (2013) Gulsen Ozen et al. JOINT BONE SPINE
- 25-Hydroxyvitamin D status does not affect the clinical rituximab response in rheumatoid arthritis
- (2013) Rim Ben M’Barek et al. JOINT BONE SPINE
- A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
- (2013) James D Mellor et al. Journal of Hematology & Oncology
- Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis
- (2013) J. Sautner et al. RHEUMATOLOGY
- Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry
- (2013) S. Godot et al. ARTHRITIS CARE & RESEARCH
- Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Markus Bredemeier et al. ARTHRITIS CARE & RESEARCH
- Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
- (2012) A Ruyssen-Witrand et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Campylobacter fetusinfection in three rheumatoid arthritis patients treated with rituximab: Table 1
- (2012) Alain Meyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis
- (2012) Sudipto Das et al. ANNALS OF THE RHEUMATIC DISEASES
- Smoking, rheumatoid factor status and responses to rituximab
- (2012) Abdul Khan et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-associated Colitis
- (2012) Mahesh Bhalme et al. INFLAMMATORY BOWEL DISEASES
- Knee tuberculosis under rituximab therapy for rheumatoid arthritis
- (2012) Sébastien Ottaviani et al. JOINT BONE SPINE
- Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis
- (2012) Ko-Ming Lin et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Atypical Psoriasis Following Rituximab for Rheumatoid Arthritis
- (2012) S. A. HARDCASTLE et al. JOURNAL OF RHEUMATOLOGY
- Incidence of New-onset and Flare of Preexisting Psoriasis During Rituximab Therapy for Rheumatoid Arthritis: Data from the French AIR Registry
- (2012) L. THOMAS et al. JOURNAL OF RHEUMATOLOGY
- Plantar pustulosis during rituximab therapy for rheumatoid arthritis
- (2012) Alexandra Maria Giovanna Brunasso et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients
- (2012) Athina Pyrpasopoulou et al. Molecular Diagnosis & Therapy
- Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients
- (2012) A. Ruyssen-Witrand et al. RHEUMATOLOGY
- Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature
- (2012) G. M. Guidelli et al. RHEUMATOLOGY INTERNATIONAL
- Rituximab or a second anti-TNF therapy for rheumatoid arthritis patients who have failed their first anti-TNF? Comparative analysis from the British Society for Rheumatology Biologics Register
- (2012) Moetaza M. Soliman et al. ARTHRITIS CARE & RESEARCH
- Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
- (2012) M. Couderc et al. ARTHRITIS CARE & RESEARCH
- Interferon type I signature may predict non response upon rituximab in rheumatoid arthritis patients
- (2012) Hennie G Raterman et al. ARTHRITIS RESEARCH & THERAPY
- B lymphocyte-typing for prediction of clinical response to rituximab
- (2012) Hans-Peter Brezinschek et al. ARTHRITIS RESEARCH & THERAPY
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study
- (2011) Jérémie Sellam et al. ARTHRITIS AND RHEUMATISM
- Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis
- (2011) Jérémie Sellam et al. ARTHRITIS AND RHEUMATISM
- Rituximab in rheumatoid arthritis and the risk of malignancies: Report from a French cohort
- (2011) Samy Slimani et al. JOINT BONE SPINE
- Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis
- (2011) Etienne Ghrénassia et al. JOINT BONE SPINE
- TGF beta1 polymorphisms are candidate predictors of the clinical response to rituximab in rheumatoid arthritis
- (2011) Claire Immediato Daïen et al. JOINT BONE SPINE
- Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab
- (2011) Juan C. Diaz et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
- (2010) E. E. A. Arts et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re-treatment
- (2010) E. M. Vital et al. ARTHRITIS AND RHEUMATISM
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance
- (2010) C. Henry et al. BLOOD
- Pregnancy outcomes after maternal exposure to rituximab
- (2010) E. F. Chakravarty et al. BLOOD
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Effects of Early Rituximab Retreatment in Rheumatoid Arthritis Patients with an Inadequate Response After the First Cycle: Retrospective Arthritis Cohort Study
- (2010) H. BASTIAN et al. JOURNAL OF RHEUMATOLOGY
- Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment
- (2010) Mattias Magnusson et al. RHEUMATOLOGY
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
- Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate
- (2010) William Rigby et al. ARTHRITIS CARE & RESEARCH
- Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment
- (2010) Maria Rehnberg et al. ARTHRITIS RESEARCH & THERAPY
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis
- (2009) Véronique Parietti et al. CLINICAL IMMUNOLOGY
- Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells
- (2009) Antonio Julià et al. PHARMACOGENOMICS
- Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis
- (2009) L. Quartuccio et al. RHEUMATOLOGY
- Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis
- (2009) Athina Pyrpasopoulou et al. RHEUMATOLOGY INTERNATIONAL
- Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
- (2009) Magda Nakou et al. ARTHRITIS RESEARCH & THERAPY
- Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy
- (2008) Sunanda V Kane et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy
- (2008) E. Keystone et al. ARTHRITIS AND RHEUMATISM
- Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis
- (2008) Shouvik Dass et al. ARTHRITIS AND RHEUMATISM
- Rituximab (MabThera) therapy and safety management. Clinical tool guide developed by the Rheumatic Diseases & Inflammation Group (Club Rhumatismes et Inflammation, CRI) of the French Society for Rheumatology (Société Française de Rhumatologie, SFR)
- (2008) Thao Pham et al. JOINT BONE SPINE
- Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis
- (2008) M. L. Burr et al. RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started